ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,744Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 298

$841K Total Retail Price of All Prescriptions

Rank: 1 out of 298

474 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 474 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 474 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 11,705 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 580 436 1 3
LEVOTHYROXINE SODIUM 575 475 2 1
SIMVASTATIN 504 430 3 2
WARFARIN SODIUM 486 478 4 7
LISINOPRIL 481 389 5 4
FUROSEMIDE 411 343 6 5
POTASSIUM CHLORIDE 397 362 7 11
AMLODIPINE BESYLATE 378 336 8 6
TRAMADOL HCL 286 238 9 15
FENTANYL 256 253 S2 10 32
HYDROCODONE-ACETAMINOPHEN 251 214 S3 11 8
HYDROCHLOROTHIAZIDE 237 206 12 13
ZOLPIDEM TARTRATE 200 198 13 25
METOPROLOL SUCCINATE 194 182 14 12
METFORMIN HCL 189 167 15 10
METOPROLOL TARTRATE 186 174 16 9
PAROXETINE HCL 173 145 17 48
ALENDRONATE SODIUM 162 149 18 21
ATORVASTATIN CALCIUM 153 110 19 14
SERTRALINE HCL 139 122 20 19
LOSARTAN POTASSIUM 136 104 21 18
TRAZODONE HCL 132 107 22 39
DONEPEZIL HCL 128 128 23 22
GABAPENTIN 115 103 24 20
TAMSULOSIN HCL 111 84 25 24
CITALOPRAM HBR 105 96 26 17
CLOPIDOGREL 104 97 27 36
OXYCODONE HCL 98 92 S2 28 79
FAMOTIDINE 93 93 29 80
DIOVAN 92 92 30 47
QUETIAPINE FUMARATE 88 79 31 68
DIGOXIN 87 87 32 27
NOVOLOG 86 72 33 102
CARVEDILOL 86 81 33 23
POLYETHYLENE GLYCOL 3350 83 66 35 29
PLAVIX 82 77 36 70
DETROL LA 82 60 36 151
LANTUS 81 68 38 53
OXYBUTYNIN CHLORIDE 80 68 39 81
OXYCODONE-ACETAMINOPHEN 80 51 S2 39 152
NEXIUM 79 61 41 40
ATENOLOL 79 65 41 16
CEPHALEXIN 77 68 43 94
CYMBALTA 76 72 44 67
LIDODERM 76 74 44 161
ENALAPRIL MALEATE 74 62 46 58
FLUTICASONE PROPIONATE 72 46 47 38
NAPROXEN 72 49 47 148
PRAVASTATIN SODIUM 70 63 49 31
GENERLAC 68 49 50 143
SPIRONOLACTONE 68 43 50 34
TERAZOSIN HCL 67 63 52 72
MIRTAZAPINE 66 66 53 37
BACLOFEN 65 14 54 97
AMLODIPINE BESYLATE-BENAZEPRIL 64 64 55 98
BUMETANIDE 62 62 56 71
MELOXICAM 61 55 57 41
VENLAFAXINE HCL ER 61 47 57 90
CARBIDOPA-LEVODOPA 60 60 59 49
IBUPROFEN 60 32 59 126
CIPROFLOXACIN HCL 59 49 61 56
CLONIDINE HCL 57 55 62 82
NAMENDA 57 57 62 35
PREDNISONE 56 47 64 33
AZITHROMYCIN 55 43 65 63
ALLOPURINOL 54 54 66 28
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 40 67 118
ACTOS 52 37 67 137
ROPINIROLE HCL 52 29 67 117
CELEBREX 51 40 70 86
NYSTATIN 51 42 70 239
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 5, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.